The abnormal levels of these factors may induce fatigue through various mechanisms, including the regulation of indoleamine 2,3-dioxygenase by inflammatory factors, potentially explaining the observed fatigue symptoms in SLE and ME/CFS (50–53). The gene discussed is IDO2; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.